<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/32ccc8e8-dbcf-4605-800a-d4dc0a65419a/B42E4272-8210-4BEA-BAB6-6C9EBD25CE1C/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.forbes.com/2009/05/30/oncology-asco-cancer-drugs-business-healthcare-tarceva.html" href="http://www.forbes.com/2009/05/30/oncology-asco-cancer-drugs-business-healthcare-tarceva.html" style="font-size: 11px;">www.forbes.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/2009/05/30/oncology-asco-cancer-drugs-business-healthcare-tarceva.html"><H2>Drug companies are making big profits from very small increases in cancer drug effectiveness.</H2></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/2009/05/30/oncology-asco-cancer-drugs-business-healthcare-tarceva.html"><P>But many companies seem to be maximizing cancer profit instead. Big drug companies are making big money off smaller and smaller improvements in cancer care. Newfangled cancer drugs can cost $50,000 a year, and that doesn’t mean they will add a year to the patient’s life--you might spend $50,000 for a year and extend the patient's life by only weeks.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/2009/05/30/oncology-asco-cancer-drugs-business-healthcare-tarceva.html">The skyrocketing costs for limited benefit are leading some experts to worry about whether the medical system has the right incentives</blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/2009/05/30/oncology-asco-cancer-drugs-business-healthcare-tarceva.html">We are wasting a lot of resources treating people with treatments they don't need," says Otis Brawley, chief medical officer at the American Cancer Society. <SPAN class=tickerlinx><A href="http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=NVS"><B>Novartis</B></A></SPAN> ( <A href="http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=NVS">NVS</A> - <A href="http://search.forbes.com/search/CompanyNewsSearch?ticker=NVS">news </A>- <A href="http://people.forbes.com/search?ticker=NVS">people </A>), <SPAN class=tickerlinx><A href="http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=WYE"><B>Wyeth</B></A></SPAN> ( <A href="http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=WYE">WYE</A> - <A href="http://search.forbes.com/search/CompanyNewsSearch?ticker=WYE">news </A>- <A href="http://people.forbes.com/search?ticker=WYE">people </A>) and <SPAN class=tickerlinx><A href="http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=PFE"><B>Pfizer</B></A></SPAN> ( <A href="http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=PFE">PFE</A> - <A href="http://search.forbes.com/search/CompanyNewsSearch?ticker=PFE">news </A>- <A href="http://people.forbes.com/search?ticker=PFE">people </A>) all sell very expensive cancer pills. "We would like to believe that cost should be no object, but that is not reality,</blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/B42E4272-8210-4BEA-BAB6-6C9EBD25CE1C/blog/" title="blog or email this clip"><img src="http://content9.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks:  Amplify.com - Don't just share the news...Amplify it!